The usefulness of factor XIII levels in Crohn's disease

摘要

Background and Aims: The assessment of inflammatory activity in Crohn's disease (CD) is challenging, and no specific laboratory marker is currently available. Several studies have reported decreased serum factor XIII levels in CD patients as a function of disease activity. We aimed to determine whether the factor XIII level could be a marker for the evolution of CD. Methods: In this prospective, single-centre trial, 129 patients were included and categorised into two groups: functional bowel disorders (FBDs, n. =. 42) and CD (n. =. 86). The CD group was divided into two subgroups depending on disease activity, as defined by the Crohn's Disease Activity Index score: active disease (CDa, n. =. 41) and disease remission (CDb, n. =. 45). The factor XIII levels were evaluated for each patient. Serial factor XIII levels were evaluated in the patients within the CDa subgroup. Results: The factor XIII levels were significantly different between the FBD (117.69%) and CD (101.89%) groups (p. =. 0.009) but there was no significant difference between the CDa and CDb subgroups (99.04% vs 104.65%, p. >. 0.05), and the levels did not vary during follow-up for the patients in the CDa subgroup. By multivariate analysis, factor XIII levels did not correlate with the time course of disease evolution, CRP, serum fibrin levels, platelet count, disease distribution within the bowel, or the presence of a fistulising form of CD. Conclusions: Our results confirm that factor XIII levels are decreased in CD patients but cannot be recommended as a marker for the disease activity.